Skip to content
mapperlab
← Dashboard
Stock

ABEV

AMBEV S.A.
Latest close $3.147 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
7
27 funds tracked
Ever held
9
Current + past
New this quarter
1
Exited this quarter
0

Marquee-fund ownership over time

Feb 14, 2014May 15, 2018Nov 14, 2024May 15, 2026
Now
7

This quarter's activity

New positions opened

Positions exited

None.

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Renaissance Technologies$2.09$3.14+50%
Citadel Advisors re-entered$2.14$3.14+47%
Two Sigma Investments$2.14$3.14+47%
D.E. Shaw$2.14$3.14+47%
AQR Capital Management$2.14$3.14+47%
Millennium Management$2.14$3.14+47%
Point72 Asset Management re-entered$2.14$3.14+47%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Maverick Capital 3× in & out→ $3.10-16%
Viking Global Investors→ $3.60-16%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at AMBEV S.A.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
9
Filings · last 90d
9
Total on file
9
Recent SEC buffer
Most recent
Apr 13, 2026

30d / 90d windows measured from Apr 13, 2026 — the most recent Form 4 on file — not from today.

Fundamentals

XBRL · AMBEV S.A.

Not enough XBRL history to plot. AMBEV S.A.hasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for AMBEV S.A. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Point72 Asset ManagementQ2 2026open$3.07$3.14+2%
Citadel AdvisorsQ4 2025open$2.55$3.14+23%
Citadel AdvisorsQ1 2025Q2 2025$1.85$2.49+35%
Point72 Asset ManagementQ1 2025Q1 2026$1.85$3.08+67%
Citadel AdvisorsQ3 2024Q4 2024$2.14$2.03-5%
Two Sigma InvestmentsQ3 2024open$2.14$3.14+47%
D.E. ShawQ3 2024open$2.14$3.14+47%
AQR Capital ManagementQ3 2024open$2.14$3.14+47%
Millennium ManagementQ3 2024open$2.14$3.14+47%
Point72 Asset ManagementQ3 2024Q4 2024$2.14$2.03-5%
Renaissance TechnologiesQ3 2024open$2.09$3.14+50%
Maverick CapitalQ3 2018Q4 2018$3.70$3.10-16%
Maverick CapitalQ1 2018Q2 2018$4.89$4.26-13%
Viking Global InvestorsQ1 2015Q3 2015$4.27$3.60-16%
Maverick CapitalQ1 2014Q4 2014$4.40$4.02-9%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.